Matthew Herper is a senior writer at STAT covering medicine, and oversees the editorial portion of STAT’s events, including its industry-leading Summits. He has covered medical innovation — both its promise and its perils — for two decades, writing about medicines from Lipitor to hydroxychloroquine and profiling figures from “pharma bro” Martin Shkreli to billionaire Bill Gates. Before joining STAT in 2019, he worked for 18 years at Forbes, where he wrote 17 cover stories.